The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Self-citationCD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Heng, D. Y. C., Xie, W., Regan, M. M., Warren, M. A., Golshayan, A. R., Sahi, C., Eigl, B. J., Ruether, J. D., Cheng, T., North, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4809 · Cited by 2,133
Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Wilding, G., Figlin, R. A., Ginsberg, M. S., Kim, S. T., Baum, C. M., DePrimo, S. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2574 · Cited by 1,634
Motzer, R. J., Bacik, J., Murphy, B. A., Russo, P., & Mazumdar, M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.289 · Cited by 1,576
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512
Ghiringhelli, F., Menard, C., Puig, P. E., Ladoire, S., Roux, S., Martin, F., Solary, E., Le Cesne, A., Zitvogel, L., & Chauffert, B. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0225-8 · Cited by 1,241
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,174
Kantoff, P. W., Schuetz, T. J., Blumenstein, B. A., Glode, L. M., Bilhartz, D. L., Wyand, M., Manson, K., Panicali, D. L., Laus, R., Schlom, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0597 · Cited by 982
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J., Gailani, F., Riley, L., Conlon, K., Pockaj, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012863 · Cited by 911
Lutsiak, M. E. C., Semnani, R. T., De Pascalis, R., Kashmiri, S. V. S., Schlom, J., & Sabzevari, H. (2005) · Blood · doi:10.1182/blood-2004-06-2410 · Cited by 903
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867
Ko, J. S., Zea, A. H., Rini, B. I., Ireland, J. L., Elson, P., Cohen, P., Golshayan, A., Rayman, P. A., Wood, L., Garcia, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1332 · Cited by 862
Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 851
Phenotypical and functional specialization of FOXP3+ regulatory T cells
Campbell, D. J., & Koch, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri2916 · Cited by 773
Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., & Rivoltini, L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5829 · Cited by 647
Speiser, D. E., Líénard, D., Rufer, N., Rubio‐Godoy, V., Rimoldi, D., Lejeune, F. J., Krieg, A. Μ., Cerottini, J., & Romero, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523373 · Cited by 640
Myeloid-derived suppressor cell heterogeneity and subset definition
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., & Bronte, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.021 · Cited by 630
Self-citationProminent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628
Orchestrating the orchestrators: chemokines in control of T cell traffic
Bromley, S. K., Mempel, T. R., & Luster, A. D. (2008) · Nature Immunology · doi:10.1038/ni.f.213 · Cited by 593
Mirza, N., Fishman, M., Fricke, I., Dunn, M., Neuger, A. M., Frost, T. J., Lush, R. M., Antonia, S., & Gabrilovich, D. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1690 · Cited by 564
Brossart, P., Wirths, S., Stuhler, G., Reichardt, V. L., Kanz, L., & Brugger, W. (2000) · Blood · doi:10.1182/blood.v96.9.3102 · Cited by 552
Self-citationPittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Liénard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.-C., & Romero, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.705 · Cited by 508
Finke, J. H., Rini, B., Ireland, J., Rayman, P., Richmond, A., Golshayan, A., Wood, L., Elson, P., Garcia, J., Dreicer, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5212 · Cited by 492
Kryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A., & Zou, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6730 · Cited by 416
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902661 · Cited by 414
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., Iafrate, M., Prayer-Galetti, T., Pagano, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042028 · Cited by 396
Self-citationSolito, S., Falisi, E., Diaz-Montero, C. M., Doni, A., Pinton, L., Rosato, A., Francescato, S., Basso, G., Zanovello, P., Onicescu, G., et al. (2011) · Blood · doi:10.1182/blood-2010-12-325753 · Cited by 337
Self-citationParham, P., & Brodsky, F. M. (1981) · Human Immunology · doi:10.1016/0198-8859(81)90065-3 · Cited by 320
Brossart, P., Heinrich, K. S., Stuhler, G., Behnke, L., Reichardt, V. L., Stevanovic, S., Muhm, A., Rammensee, H.-G., Kanz, L., & Brugger, W. (1999) · Blood · doi:10.1182/blood.v93.12.4309 · Cited by 306
Self-citationIL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S., Zanon, A., Rossi, C. R., Nitti, D., Bronte, V., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803831 · Cited by 304
Self-citationHipp, M. M., Hilf, N., Walter, S., Werth, D., Brauer, K. M., Radsak, M. P., Weinschenk, T., Singh-Jasuja, H., & Brossart, P. (2008) · Blood · doi:10.1182/blood-2007-02-075945 · Cited by 288
Self-citationReversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
Kusmartsev, S., Su, Z., Heiser, A., Dannull, J., Eruslanov, E., Kübler, H., Yancey, D., Dahm, P., & Vieweg, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0165 · Cited by 284
The prevalence of Th17 cells in patients with gastric cancer
Zhang, B., Rong, G., Wei, H., Zhang, M., Bi, J., Ma, L., Xue, X., Wei, G., Liu, X., & Fang, G. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.060 · Cited by 257
Schuster, S. J., Neelapu, S. S., Gause, B. L., Janik, J. E., Muggia, F. M., Gockerman, J. P., Winter, J. N., Flowers, C. R., Nikcevich, D. A., Sotomayor, E. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3005 · Cited by 247
Semmling, V., Lukacs-Kornek, V., Thaiss, C. A., Quast, T., Hochheiser, K., Panzer, U., Rossjohn, J., Perlmutter, P., Cao, J., Godfrey, D. I., et al. (2010) · Nature Immunology · doi:10.1038/ni.1848 · Cited by 234
Wierecky, J., Müller, M. R., Wirths, S., Halder-Oehler, E., Dörfel, D., Schmidt, S. M., Häntschel, M., Brugger, W., Schröder, S., Horger, M. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3905 · Cited by 228
Self-citationOptimizing a Multicolor Immunophenotyping Assay
Mahnke, Y. D., & Roederer, M. (2007) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2007.05.002 · Cited by 202
Burger, D., & Dayer, J.-M. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(01)00018-0 · Cited by 202
Andrew, D. P., Ruffing, N., Kim, C. H., Miao, W., Heath, H., Li, Y., Murphy, K. E., Campbell, J. J., Butcher, E. C., & Wu, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.103 · Cited by 201
Brossart, P., Schneider, A., Dill, P. E., Schammann, T., Grünebach, F., Wirths, S., Kanz, L., Bühring, H., & Brugger, W. (2001) · PubMed · Cited by 200
Self-citationIntegrated functional genomics approach for the design of patient-individual antitumor vaccines.
Weinschenk, T., Gouttefangeas, C., Schirle, M., Obermayr, F., Walter, S., Schoor, O., Kurek, R., Loeser, W., Bichler, K., Wernet, D., et al. (2002) · PubMed · Cited by 190
Self-citationDifferent mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide
Motoyoshi, Y., Kaminoda, K., Saitoh, O., Hamasaki, K., Nakao, K., Ishii, N., Nagayama, Y., & Eguchi, K. (2006) · Oncology Reports · doi:10.3892/or.16.1.141 · Cited by 161
Britten, C. M., Gouttefangeas, C., Welters, M. J. P., Pawelec, G., Koch, S. D., Ottensmeier, C. H. H., Mander, A., Walter, S., Paschen, A., Müller‐Berghaus, J., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0378-0 · Cited by 143
Self-citationKirkwood, J. M., Lee, S., Moschos, S. J., Albertini, M. R., Michalak, J. C., Sander, C., Whiteside, T. L., Butterfield, L. H., & Weiner, L. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1231 · Cited by 138
Speiser, D. E., Baumgaertner, P., Voelter, V., Devêvre, E., Barbey, C., Rufer, N., & Romero, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800080105 · Cited by 137
Chianese‐Bullock, K. A., Pressley, J., Garbee, C. F., Hibbitts, S., Murphy, C., Yamshchikov, G. V., Petroni, G. R., Bissonette, E. A., Neese, P. Y., Grosh, W. W., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3080 · Cited by 126
Britten, C. M., Meyer, R. G., Kreer, T., Drexler, I., Wölfel, T., & Herr, W. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00499-9 · Cited by 124
Singh‐Jasuja, H., Emmerich, N., & Rammensee, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0480-x · Cited by 124
Self-citationDerhovanessian, E., Adams, V., Hähnel, K., Groeger, A., Pandha, H., Ward, S., & Pawelec, G. (2009) · International Journal of Cancer · doi:10.1002/ijc.24497 · Cited by 122
Self-citationMuntoni, S., Atzori, L., Mereu, R., Satta, G., Macis, M. D., Congia, M., Tedde, A., Desogus, A., & Muntoni, S. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.06.002 · Cited by 86
Towards patient‐specific tumor antigen selection for vaccination
Rammensee, H., Weinschenk, T., Gouttefangeas, C., & Eq, S. S. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18815.x · Cited by 84
Self-citationWalker, E., Haley, D. P., Miller, W. L., Floyd, K., Wisner, K. P., Sanjuan, N., Maecker, H. T., Romero, P. J., Hu, H., Alvord, W. G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0095-03 · Cited by 79
Schmidt, S. M., Schag, K., Müller, M., Weinschenk, T., Appel, S., Schoor, O., Weck, M. M., Grünebach, F., Kanz, L., Stevanović, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2538 · Cited by 73
Self-citationLíénard, D., Rimoldi, D., Marchand, M., Dietrich, P., van Baren, N., Geldhof, C., Batard, P., Guillaume, P., Ayyoub, M., Pittet, M. J., et al. (2004) · PubMed · Cited by 72
Self-citationKrüger, T., Schoor, O., Lemmel, C., Kraemer, B. F., Reichle, C., Dengjel, J., Weinschenk, T., Müller, M., Hennenlotter, J., Stenzl, A., et al. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0650-5 · Cited by 70
Self-citationUnexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas
Dengjel, J., Nastke, M.-D., Gouttefangeas, C., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2470 · Cited by 68
Walter, S., Herrgen, L., Schoor, O., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4974 · Cited by 64
Self-citationBertoletti, A., Southwood, S., Chesnut, R. W., Sette, A., Falco, M., Ferrara, G. B., Penna, A., Boni, C., Fiaccadori, F., & Ferrari, C. I. (1997) · Hepatology · doi:10.1002/hep.510260435 · Cited by 59
Kanagawa, N., Niwa, M., Hatanaka, Y., Tani, Y., Nakagawa, S., Fujita, T., Yamamoto, A., & Okada, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.22908 · Cited by 54
Boß, C. N., Grünebach, F., Brauer, K. M., Häntschel, M., Mirakaj, V., Weinschenk, T., Stevanović, S., Rammensee, H., & Brossart, P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2156 · Cited by 51
Self-citationReal, E., Kaiser, A., Raposo, G., Amara, A., Nardin, A., Trautmann, A., & Donnadieu, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.50 · Cited by 50
Schag, K., Schmidt, S. M., Müller, M., Weinschenk, T., Appel, S., Weck, M. M., Grünebach, F., Stevanović, S., Rammensee, H., & Brossart, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0640 · Cited by 47
Self-citationEx vivoDetectable Human CD8 T-Cell Responses to Cancer-Testis Antigens
Baumgaertner, P., Rufer, N., Devêvre, E., Derré, L., Rimoldi, D., Geldhof, C., Voelter, V., Líénard, D., Romero, P. J., & Speiser, D. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3793 · Cited by 47
Walter, S., Bioley, G., Bühring, H., Koch, S. D., Wernet, D., Zippelius, A., Pawelec, G., Romero, P. J., Stevanović, S., Rammensee, H., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526207 · Cited by 27
Self-citationTuovinen, H., Laurinolli, T.-T., Rossi, L. H., Pekkarinen, P. T., Mattila, I. P., & Arstila, T. P. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.01.004 · Cited by 14
Cited by
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Self-citationTowards personalized, tumour-specific, therapeutic vaccines for cancer
Hu, Z., Ott, P. A., & Wu, C. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.131 · Cited by 1,067
Actively personalized vaccination trial for newly diagnosed glioblastoma
Hilf, N., Kuttruff-Coqui, S., Frenzel, K., Bukur, V., Stevanović, S., Gouttefangeas, C., Platten, M., Tabatabai, G., Dutoit, V., van der Burg, S. H., et al. (2019) · Nature · doi:10.1038/s41586-018-0810-y · Cited by 938
Self-citationDendritic-Cell-Based Therapeutic Cancer Vaccines
Palucka, K., & Banchereau, J. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.004 · Cited by 869
De Simone, M., Arrigoni, A., Rossetti, G., Gruarin, P., Ranzani, V., Politano, C., Bonnal, R. J. P., Provasi, E., Sarnicola, M. L., Panzeri, I., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.021 · Cited by 687
Metadata
- Authors
- Walter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Staehler, M., Brugger, W., Dietrich, P.-Y., Mendrzyk, R., Hilf, N., Schoor, O., Fritsche, J., Mahr, A., Maurer, D., Vass, V., Trautwein, C., Lewandrowski, P., Flohr, C., Pohla, H., Stanczak, J. J., Bronte, V., Mandruzzato, S., Biedermann, T., Pawelec, G., Derhovanessian, E., Yamagishi, H., Miki, T., Hongo, F., Takaha, N., Hirakawa, K., Tanaka, H., Stevanovic, S., Frisch, J., Mayer-Mokler, A., Kirner, A., Rammensee, H.-G., Reinhardt, C., & Singh-Jasuja, H.
- Venue
- Nature Medicine
- Published
- 2012-07-29
- Volume
- 18
- Issue
- 8
- Pages
- 1254-1261
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2082830752
- Cited by
- 788
- References
- 67
- FWCI
- 38.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.